The Ponca Tribe of Oklahoma received a $1,000,000 Project Grant award under the U.S. Department of Justice's Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program (CFDA # 16.838). This 3-year grant will enable the tribe to provide a range of evidence-based treatment, recovery support services, court-based intervention programming, naloxone distribution, and controlled substance take-back initiatives for its members and surrounding tribal communities. The project aims to...
The Ponca Tribe of Nebraska received a $360,000 Project Grant award from the Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Community Mental Health Services program (CFDA 93.958). The grant will fund the Ponca Tribe of Nebraska Native Connections (PTN-Native Connections) project, which aims to improve mental health and substance use outcomes for tribal youth up to age 24 through prevention, intervention,...
The Pawnee Nation of Oklahoma received a $750,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant's purpose is to assist in addressing the opioid overdose crisis in tribal communities by increasing access to medications for opioid use disorder (MOUD) and supporting a continuum of prevention, harm reduction, treatment,...
The Peoria Tribe of Indians of Oklahoma received a $750,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant will support a comprehensive program to address the opioid overdose crisis and behavioral health challenges within the tribal community in Ottawa County, Oklahoma. Key activities include increasing access to...
The Osage Nation Si-Si A-Pe-Txa was awarded a $386,902 Project Grant by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant will fund the Osage Nation Si-Si A-Pe-Txa's Tribal Opioid Response project, which aims to build a supportive community for Native Americans in recovery from substance use disorders. Key project activities include:...
The Citizen Potawatomi Nation (CPN) in Shawnee, Oklahoma was awarded a $2,386,901 Project Grant by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The CPN Tribal Opioid Response (TOR) program will use this funding over a 5-year period from September 2024 to September 2029 to address the opioid overdose crisis in the CPN tribal community. Key services...
This Project Grant award of $870,140, provided by the U.S. Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, supports the Prairie Band Potawatomi Nation's Tribal Opioid Response (TOR) program. The TOR program aims to significantly reduce substance use disorder, particularly opioid misuse, among both adults and youth...
The Seneca Cayuga Tribe of Oklahoma was awarded a $1,000,000 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. This initiative aims to address the critical issue of opioid and other substance abuse disorders within the Seneca Cayuga Tribe and 12 surrounding tribal nations by partnering with local addiction treatment facilities, Rolling...
The Cheyenne and Arapaho Tribes have been awarded a $1,082,731 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The 5-year grant, beginning on September 30, 2024, will support the Tribes' Tribal Opioid Response (TOR) program in delivering a continuum of culturally appropriate, evidence-based prevention and mentoring strategies to...
This $386,902 federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under CFDA 93.243 - Substance Abuse and Mental Health Services Projects of Regional and National Significance, is intended to assist in addressing the opioid overdose crisis in tribal communities. The primary objectives are to increase access to FDA-approved medications for the treatment of opioid use disorder (MOUD) and support the continuum of care. Key activities to be...
The Ponca Tribe of Oklahoma received a $750,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant, awarded on September 30, 2024, will support the Ponca Tribe Opioid Response Program over a 5-year period through September 29, 2029.
The key products and services to be delivered under this grant include: 1) Strengthening treatment options, increasing recovery services, and implementing harm reduction services for youth up to age 17 and adults ages 18+ within the Ponca Tribe's service area and surrounding communities; 2) Initiating prevention activities, including quarterly events to educate, decrease substance use, and prevent overdoses; and 3) Building capacity by strengthening partnerships with non-Native organizations to improve client engagement in non-tribal resources. The project aims to lay the groundwork for an integrated approach to medication-assisted treatment and substance use disorder treatment across the Ponca Tribe and three neighboring tribes, while also reducing relapse and increasing sustained recovery.